{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T10:24:57Z","timestamp":1781259897499,"version":"3.54.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Cardiovasc. Transl. Res."],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s12265-025-10625-y","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T09:20:22Z","timestamp":1748510422000},"page":"983-992","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Clinical Significance of miR-139-5p in Acute Coronary Syndrome and its Potential Effect on the Progression of Acute Coronary Syndrome"],"prefix":"10.1007","volume":"18","author":[{"given":"Zhe","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoli","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0412-3058","authenticated-orcid":false,"given":"Fei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"10625_CR1","doi-asserted-by":"publisher","unstructured":"Shin M, Mun S, Park SH, Lee J, Kang HG. Serum biomarker discovery related to pathogenesis in acute coronary syndrome by proteomic approach. Bioscie Rep. 2021;41. https:\/\/doi.org\/10.1042\/bsr20210344.","DOI":"10.1042\/bsr20210344"},{"key":"10625_CR2","doi-asserted-by":"publisher","first-page":"3834128","DOI":"10.1155\/2020\/3834128","volume":"2020","author":"Z Shi","year":"2020","unstructured":"Shi Z, Zhao C, Hu J, Dai Q, Guan M, Zhong C, Tian G, Shang H. The application of traditional Chinese medicine injection on patients with acute coronary syndrome during the perioperative period of percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials. Evid-based Complement Altern Med eCAM. 2020;2020:3834128. https:\/\/doi.org\/10.1155\/2020\/3834128.","journal-title":"Evid-based Complement Altern Med eCAM"},{"key":"10625_CR3","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12872-023-03387-5","volume":"23","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Song X, Ma Y, Liu X, Peng Y. Circulating mir-483-5p as a novel diagnostic biomarker for acute coronary syndrome and its predictive value for the clinical outcome after PCI. BMC Cardiovasc Disord. 2023;23:360. https:\/\/doi.org\/10.1186\/s12872-023-03387-5.","journal-title":"BMC Cardiovasc Disord"},{"key":"10625_CR4","doi-asserted-by":"publisher","first-page":"e048994","DOI":"10.1136\/bmjopen-2021-048994","volume":"11","author":"JQ Mol","year":"2021","unstructured":"Mol JQ, Belkacemi A, Volleberg RH, Meuwissen M, Protopopov AV, Laanmets P, Krestyaninov OV, Dennert R, Oemrawsingh RM, van Kuijk JP, Arkenbout K, van der Heijden DJ, Rasoul S, Lipsic E, Teerenstra S, Camaro C, Damman P, van Leeuwen MA, van Geuns RJ, van Royen N. Identification of anatomic risk factors for acute coronary events by optical coherence tomography in patients with myocardial infarction and residual nonflow limiting lesions: rationale and design of the PECTUS-obs study. BMJ Open. 2021;11:e048994. https:\/\/doi.org\/10.1136\/bmjopen-2021-048994.","journal-title":"BMJ Open"},{"key":"10625_CR5","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1002\/jcp.27486","volume":"234","author":"K Saliminejad","year":"2019","unstructured":"Saliminejad K, Khorram Khorshid HR, Soleymani Fard S, Ghaffari SH. An overview of microRNAs: Biology, functions, therapeutics, and analysis methods. J Cell Physiol. 2019;234:5451\u201365. https:\/\/doi.org\/10.1002\/jcp.27486.","journal-title":"J Cell Physiol"},{"key":"10625_CR6","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.tig.2022.02.006","volume":"38","author":"C Diener","year":"2022","unstructured":"Diener C, Keller A, Meese E. Emerging concepts of miRNA therapeutics: from cells to clinic. Trends Gene TIG. 2022;38:613\u201326. https:\/\/doi.org\/10.1016\/j.tig.2022.02.006.","journal-title":"Trends Gene TIG"},{"key":"10625_CR7","doi-asserted-by":"publisher","first-page":"e23608","DOI":"10.1002\/jcla.23608","volume":"35","author":"D Sun","year":"2021","unstructured":"Sun D, Ma T, Zhang Y, Zhang F, Cui B. Overexpressed miR-335-5p reduces atherosclerotic vulnerable plaque formation in acute coronary syndrome. J Clin Lab Anal. 2021;35:e23608. https:\/\/doi.org\/10.1002\/jcla.23608.","journal-title":"J Clin Lab Anal"},{"key":"10625_CR8","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s12872-017-0653-8","volume":"17","author":"R Bai","year":"2017","unstructured":"Bai R, Yang Q, Xi R, Li L, Shi D, Chen K. miR-941 as a promising biomarker for acute coronary syndrome. BMC Cardiovasc Disord. 2017;17:227. https:\/\/doi.org\/10.1186\/s12872-017-0653-8.","journal-title":"BMC Cardiovasc Disord"},{"key":"10625_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12872-021-01891-0","volume":"21","author":"W Zhang","year":"2021","unstructured":"Zhang W, Chang G, Cao L, Ding G. Dysregulation of serum miR-361-5p serves as a biomarker to predict disease onset and short-term prognosis in acute coronary syndrome patients. BMC Cardiovasc Disord. 2021;21:74. https:\/\/doi.org\/10.1186\/s12872-021-01891-0.","journal-title":"BMC Cardiovasc Disord"},{"key":"10625_CR10","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1186\/s12872-024-04088-3","volume":"24","author":"S Zhang","year":"2024","unstructured":"Zhang S, Yang G, Chen Y, Liu W. miR-223-5p serves as a diagnostic biomarker for acute coronary syndrome and its predictive value for the clinical outcome after PCI. BMC Cardiovasc Disord. 2024;24:423. https:\/\/doi.org\/10.1186\/s12872-024-04088-3.","journal-title":"BMC Cardiovasc Disord"},{"key":"10625_CR11","doi-asserted-by":"publisher","unstructured":"Wojciechowska A, Braniewska A, Kozar-Kami\u0144ska K.\u00a0 MicroRNA in cardiovascular biology and disease. Adv Clin Exp Med Off Organ Wroclaw Med Univ.\u00a02017;26:865\u2013874. https:\/\/doi.org\/10.17219\/acem\/62915.","DOI":"10.17219\/acem\/62915"},{"key":"10625_CR12","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1186\/s12872-021-02211-2","volume":"21","author":"L Liu","year":"2021","unstructured":"Liu L, Zhang J, Wu M, Xu H. Identification of key miRNAs and mRNAs related to coronary artery disease by meta-analysis. BMC Cardiovasc Disord. 2021;21:443. https:\/\/doi.org\/10.1186\/s12872-021-02211-2.","journal-title":"BMC Cardiovasc Disord"},{"key":"10625_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.yjmcc.2020.04.014","volume":"151","author":"E Kayvanpour","year":"2021","unstructured":"Kayvanpour E, Gi WT, Sedaghat-Hamedani F, Lehmann DH, Frese KS, Haas J, Tappu R, Samani OS, Nietsch R, Kahraman M, Fehlmann T, M\u00fcller-Hennessen M, Weis T, Giannitsis E, Niederdr\u00e4nk T, Keller A, Katus HA, Meder B. microRNA neural networks improve diagnosis of acute coronary syndrome (ACS). J Mol Cell Cardiol. 2021;151:155\u201362. https:\/\/doi.org\/10.1016\/j.yjmcc.2020.04.014.","journal-title":"J Mol Cell Cardiol"},{"key":"10625_CR14","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1002\/ccd.24776","volume":"82","author":"PT O'Gara","year":"2013","unstructured":"O\u2019Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX. 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American college of cardiology foundation\/American heart association task force on practice guidelines: developed in collaboration with the American college of emergency physicians and society for cardiovascular angiography and interventions. Catheter Cardiovasc Interv Off J Soc Card Angiography Interv. 2013;82:E1-27. https:\/\/doi.org\/10.1002\/ccd.24776.","journal-title":"Catheter Cardiovasc Interv Off J Soc Card Angiography Interv"},{"key":"10625_CR15","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","volume":"64","author":"EA Amsterdam","year":"2014","unstructured":"Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, Jaffe AS, Jneid H, Kelly RF, Kontos MC, Levine GN, Liebson PR, Mukherjee D, Peterson ED, Sabatine MS, Smalling RW, Zieman SJ. 2014 AHA\/ACC Guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American college of cardiology\/American heart association task force on practice guidelines. J Am Coll Cardiol. 2014;64:e139\u2013228. https:\/\/doi.org\/10.1016\/j.jacc.2014.09.017.","journal-title":"J Am Coll Cardiol"},{"key":"10625_CR16","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/j.jacc.2014.07.017","volume":"64","author":"SD Fihn","year":"2014","unstructured":"Fihn SD, Blankenship JC, Alexander KP, Bittl JA, Byrne JG, Fletcher BJ, Fonarow GC, Lange RA, Levine GN, Maddox TM, Naidu SS, Ohman EM, Smith PK. 2014 ACC\/AHA\/AATS\/PCNA\/SCAI\/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American college of cardiology\/American heart association task force on practice guidelines, and the american association for thoracic surgery, preventive cardiovascular nurses association, society for cardiovascular angiography and interventions, and society of thoracic surgeons. J Am Coll Cardiol. 2014;64:1929\u201349. https:\/\/doi.org\/10.1016\/j.jacc.2014.07.017.","journal-title":"J Am Coll Cardiol"},{"key":"10625_CR17","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","volume":"34","author":"G Montalescot","year":"2013","unstructured":"Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, Bugiardini R, Crea F, Cuisset T, Di Mario C, Ferreira JR, Gersh BJ, Gitt AK, Hulot JS, Marx N, Opie LH, Pfisterer M, Prescott E, Ruschitzka F, Sabat\u00e9 M, Senior R, Taggart DP, van der Wall EE, Vrints CJ, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Knuuti J, Valgimigli M, Bueno H, Claeys MJ, Donner-Banzhoff N, Erol C, Frank H, Funck-Brentano C, Gaemperli O, Gonzalez-Juanatey JR, Hamilos M, Hasdai D, Husted S, James SK, Kervinen K, Kolh P, Kristensen SD, Lancellotti P, Maggioni AP, Piepoli MF, Pries AR, Romeo F, Ryd\u00e9n L, Simoons ML, Sirnes PA, Steg PG, Timmis A, Wijns W, Windecker S, Yildirir A, Zamorano JL. 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European society of cardiology. Eur Heart J. 2013;34:2949\u20133003. https:\/\/doi.org\/10.1093\/eurheartj\/eht296.","journal-title":"Eur Heart J"},{"key":"10625_CR18","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1002\/kjm2.12663","volume":"39","author":"W Li","year":"2023","unstructured":"Li W, Gao Z, Guan QL. Tan IIA mitigates vascular smooth muscle cell proliferation and migration induced by ox-LDL through the miR-137\/TRPC3 axis. Kaohsiung J Med Sci. 2023;39:596\u2013604. https:\/\/doi.org\/10.1002\/kjm2.12663.","journal-title":"Kaohsiung J Med Sci"},{"key":"10625_CR19","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.3892\/mmr.2018.9077","volume":"18","author":"J Su","year":"2018","unstructured":"Su J, Gao C, Wang R, Xiao C, Yang M. Genes associated with inflammation and the cell cycle may serve as biomarkers for the diagnosis and prognosis of acute myocardial infarction in a Chinese population. Mol Med Rep. 2018;18:1311\u201322. https:\/\/doi.org\/10.3892\/mmr.2018.9077.","journal-title":"Mol Med Rep"},{"key":"10625_CR20","doi-asserted-by":"publisher","first-page":"e5878","DOI":"10.7759\/cureus.5878","volume":"11","author":"RS Mushtaque","year":"2019","unstructured":"Mushtaque RS, Hameed S, Mushtaque R, Idrees M, Siraj F. Role of cardio-specific micro-ribonucleic acids and correlation with cardiac biomarkers in acute coronary syndrome: a comprehensive systematic review. Cureus. 2019;11:e5878. https:\/\/doi.org\/10.7759\/cureus.5878.","journal-title":"Cureus"},{"key":"10625_CR21","doi-asserted-by":"publisher","first-page":"48145","DOI":"10.18632\/oncotarget.18308","volume":"8","author":"S Li","year":"2017","unstructured":"Li S, Lee C, Song J, Lu C, Liu J, Cui Y, Liang H, Cao C, Zhang F, Chen H. Circulating microRNAs as potential biomarkers for coronary plaque rupture. Oncotarget. 2017;8:48145\u201356. https:\/\/doi.org\/10.18632\/oncotarget.18308.","journal-title":"Oncotarget."},{"key":"10625_CR22","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2147\/pgpm.S402750","volume":"16","author":"B Gao","year":"2023","unstructured":"Gao B, Li R, Song X, Hu S, Yang F. miR-139-5p and miR-451a as a Diagnostic Biomarker in LUSC. Pharmacogenomics Personalized Med. 2023;16:313\u201323. https:\/\/doi.org\/10.2147\/pgpm.S402750.","journal-title":"Pharmacogenomics Personalized Med"},{"key":"10625_CR23","first-page":"663","volume":"26","author":"W Meijuan","year":"2021","unstructured":"Meijuan W, Mao X, Wang S. Clinical significance of miR-139-5p and FGF2 in ovarian cancer. J BUON Off J Balkan Union Oncol. 2021;26:663\u20139.","journal-title":"J BUON Off J Balkan Union Oncol"},{"key":"10625_CR24","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.3892\/ol.2017.6351","volume":"14","author":"LL Huang","year":"2017","unstructured":"Huang LL, Huang LW, Wang L, Tong BD, Wei Q, Ding XS. Potential role of miR-139-5p in cancer diagnosis, prognosis and therapy. Oncol Lett. 2017;14:1215\u201322. https:\/\/doi.org\/10.3892\/ol.2017.6351.","journal-title":"Oncol Lett"},{"key":"10625_CR25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s12272-021-01308-8","volume":"44","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Song C, Wang T, Sun L, Qin L, Ju J. miR-139-5p promotes neovascularization in diabetic retinopathy by regulating the phosphatase and tensin homolog. Arch Pharmacal Res. 2021;44:205\u201318. https:\/\/doi.org\/10.1007\/s12272-021-01308-8.","journal-title":"Arch Pharmacal Res"},{"key":"10625_CR26","doi-asserted-by":"publisher","unstructured":"Ming S, Shui-Yun W, Wei Q, Jian-Hui L, Ru-Tai H, Lei S, Mei J, Hui W, Ji-Zheng W. miR-139-5p inhibits isoproterenol-induced cardiac hypertrophy by targetting c-Jun. Biosci Rep. 2018;38. https:\/\/doi.org\/10.1042\/bsr20171430.","DOI":"10.1042\/bsr20171430"},{"key":"10625_CR27","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1253\/circj.cj-09-0637","volume":"74","author":"G Huang","year":"2010","unstructured":"Huang G, Zhao JL, Du H, Lan XB, Yin YH. Coronary score adds prognostic information for patients with acute coronary syndrome. Circ J. 2010;74:490\u20135. https:\/\/doi.org\/10.1253\/circj.cj-09-0637.","journal-title":"Circ J"},{"key":"10625_CR28","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/ehjacc\/zuad017","volume":"12","author":"AS Espinosa","year":"2023","unstructured":"Espinosa AS, Hussain S, Al-Awar A, Jha S, Elmahdy A, Kalani M, Kakei Y, Zulfaj E, Aune E, Poller A, Bobbio E, Thoirleifsson S, Zeijlon R, Gudmundursson T, Wernbom M, Lindahl B, Polte CL, Omerovic E, Hammarsten O, Redfors B. Differences between cardiac troponin I vs. T according to the duration of myocardial ischaemia. Eur Heart J Acute Cardiovasc Care. 2023;12:355\u201363. https:\/\/doi.org\/10.1093\/ehjacc\/zuad017.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10625_CR29","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1161\/circulationaha.107.708529","volume":"116","author":"KM Eggers","year":"2007","unstructured":"Eggers KM, Lagerqvist B, Venge P, Wallentin L, Lindahl B. Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-term mortality. Circulation. 2007;116:1907\u201314. https:\/\/doi.org\/10.1161\/circulationaha.107.708529.","journal-title":"Circulation"},{"key":"10625_CR30","doi-asserted-by":"publisher","first-page":"656636","DOI":"10.3389\/fcell.2021.656636","volume":"9","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Zhang S, Ji W, Gan X, Hua L, Hou C, Chen J, Wang Y, He S, Zhou H, Jia E. LncRNA Landscape of coronary Atherosclerosis reveals differentially expressed LncRNAs in proliferation and migration of coronary artery smooth muscle cells. Front Cell Dev Biol. 2021;9:656636. https:\/\/doi.org\/10.3389\/fcell.2021.656636.","journal-title":"Front Cell Dev Biol"},{"key":"10625_CR31","doi-asserted-by":"publisher","unstructured":"Gofman JW, Lindgren F, Elliott H, Mantz W, Hewitt J, Strisower B, Herring V, Lyon TP.\u00a0The role of lipids and lipoproteins in Atherosclerosis. Science. 1950;111(2877):166\u201386. https:\/\/doi.org\/10.1126\/science.111.2877.166","DOI":"10.1126\/science.111.2877.166"},{"key":"10625_CR32","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/1755-5922.12233","volume":"35","author":"AV Palur Ramakrishnan","year":"2017","unstructured":"Palur Ramakrishnan AV, Varghese TP, Vanapalli S, Nair NK, Mingate MD. Platelet activating factor: a potential biomarker in acute coronary syndrome? Cardiovasc Ther. 2017;35:64\u201370. https:\/\/doi.org\/10.1111\/1755-5922.12233.","journal-title":"Cardiovasc Ther"},{"key":"10625_CR33","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1055\/s-0042-1742742","volume":"48","author":"OB Pedersen","year":"2022","unstructured":"Pedersen OB, Pasalic L, Nissen PH, Grove EL, Kristensen SD, Hvas AM. Flow Cytometric Assessment of Changes in Platelet Reactivity after Acute Coronary Syndrome: A Systematic Review. Semin Thromb Hemost. 2022;48:542\u201351. https:\/\/doi.org\/10.1055\/s-0042-1742742.","journal-title":"Semin Thromb Hemost"},{"key":"10625_CR34","doi-asserted-by":"publisher","first-page":"951","DOI":"10.2147\/cia.S413313","volume":"18","author":"W Wen","year":"2023","unstructured":"Wen W, Zhang Z, She J, Bai X, Wu Y, Gao L, Zhou J, Yuan Z. The Predictive Values of White Blood Cell Indices (Lymphocyte and Eosinophilic Granulocyte) for Heart Failure in Acute Coronary Syndrome Patients Following Percutaneous Coronary Intervention: A Prospective Cohort Study. Clin Interv Aging. 2023;18:951\u201362. https:\/\/doi.org\/10.2147\/cia.S413313.","journal-title":"Clin Interv Aging"},{"key":"10625_CR35","doi-asserted-by":"publisher","first-page":"153279","DOI":"10.1016\/j.tox.2022.153279","volume":"477","author":"Y Wen","year":"2022","unstructured":"Wen Y, Kong Y, Cao G, Xu Y, Zhang C, Zhang J, Xiao P, Wang Y. Di-n-butyl phthalate regulates vascular smooth muscle cells phenotypic switching by MiR-139-5p-MYOCD pathways. Toxicology. 2022;477:153279. https:\/\/doi.org\/10.1016\/j.tox.2022.153279.","journal-title":"Toxicology"},{"key":"10625_CR36","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00005-012-0192-z","volume":"60","author":"J Pelisek","year":"2012","unstructured":"Pelisek J, Eckstein HH, Zernecke A. Pathophysiological mechanisms of carotid plaque vulnerability: impact on ischemic stroke. Arch Immunol Ther Exp. 2012;60:431\u201342. https:\/\/doi.org\/10.1007\/s00005-012-0192-z.","journal-title":"Arch Immunol Ther Exp"},{"key":"10625_CR37","doi-asserted-by":"publisher","first-page":"7431","DOI":"10.1038\/s41467-024-51751-6","volume":"15","author":"P Long","year":"2024","unstructured":"Long P, Si J, Zhu Z, Jiang Y, Wang Y, Jiang Q, Li W, Xu X, You Y, Qu M, Wang H, Mo T, Liu K, Jiang J, Wang Q, Yu C, Guo Y, Millwood IY, Walters RG, He X, Yuan Y, Wang H, Zhang X, He M, Guo H, Chen Z, Li L, Lv J, Wang C, Wu T. Genome-wide DNA methylation profiling in blood reveals epigenetic signature of incident acute coronary syndrome. Nat Commun. 2024;15:7431. https:\/\/doi.org\/10.1038\/s41467-024-51751-6.","journal-title":"Nat Commun"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-025-10625-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12265-025-10625-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-025-10625-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T14:03:09Z","timestamp":1757944989000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12265-025-10625-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10625"],"URL":"https:\/\/doi.org\/10.1007\/s12265-025-10625-y","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"value":"1937-5387","type":"print"},{"value":"1937-5395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"assertion":[{"value":"11 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by Zibo First Hospital. All procedures performed in studies involving human participants were in accordance with the 1964 Helsinki Declaration and later versions. The participants'right to be informed about the study was ensured and written informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"There is no conflict of interest in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}